www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Top News

Vaccines face higher levels of scrutiny, quality control

By Wang Xiaodong | China Daily | Updated: 2019-03-12 09:00
Share
Share - WeChat
Zhang Mao, head of the State Administration of Market Regulation, speaks with reporters after a news conference on market supervision during the ongoing session of the 13th National People's Congress in Beijing on Monday. [Photo by Feng Yongbin/China Daily]

Shortcomings in anti-rabies product last year prompted oversight changes

Drug regulators and vaccine producers will face intensified scrutiny to ensure product safety and quality, a top drug supervision official said on Monday.

Vaccines are a major public health issue because they involve matters of life and death as well as national security, and efforts are now being made to establish an effective supervisory mechanism over vaccines, said Jiao Hong, head of the China Medical Products Administration.

To ensure effective supervision over the sector, the administration will focus on urging vaccine producers and local drug authorities to carry out their respective duties, Jiao said at a news conference in Beijing during the annual sessions of China's top legislative and advisory bodies.

Vaccine producers must take measures to ensure the quality of their products, including establishing sound quality control systems and product tracing systems, and also implement product risk report regulations, she said.

The administration will further clarify supervisory responsibilities on the part of local drug authorities, and urge provincial-level drug authorities to intensify site inspections over vaccine producers, she said.

The administration will increase patrols and random inspections over vaccine producers across the country, and severely punish violators, Jiao said.

Meanwhile, it will improve training of drug inspection officers to improve their efficiency, she said.

The safety and quality of drugs have been a major public concern over the past few years in China, with sporadic reports of alarming incidents such as the use of expired vaccines.

Changchun Changsheng Bio-tech Co, a major producer of a rabies vaccine in Jilin province, was found by China's top drug regulator last year to have committed various violations such as using expired materials and faking production over a four-year period.

Although no deaths or injuries linked to the case have been reported, the incident shocked the nation, prompting top officials to vow intensified supervision over the sector.

A new law, the Vaccine Administration Law, which imposes much higher penalties on violators, was drafted and submitted to the top legislature for review at the end of last year.

A Chinese medical worker prepares to vaccinate a young kid at a hospital in Shanghai, China, March 20, 2016. [Photo/IC]

Jiao said the new law will impose stricter supervision over vaccines, covering the whole manufacturing chain including research and development, production, circulation and use.

"We are working with related departments to research and formulate additional legal regulations and rules to prepare for its implementation," Jiao said.

Gao Fu, head of the Chinese Center for Disease Control and Prevention, said incidents such as the Changchun Changsheng case are just individual cases and do not represent the entire sector.

"We should not compromise our faith in the power of vaccines in disease prevention and control, nor in the quality and safety of vaccines produced in China," he said.

Fang Laiying, a member of the 13th National Committee of the Chinese People's Political Consultative Conference, China's top political advisory body, suggested during the body's ongoing annual session that a product-tracing system be established to ensure the safety and quality of vaccines.

"Every box of vaccines should have a code that stores product information, including its date of manufacture, circulation and use, so the batch can be quickly recalled if anyone reports quality problems, and users of such vaccines can be precisely identified," said Fang, who is also vice-president of the Chinese Hospital Association.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 欧美一区二区三区免费播放 | 欧美成本人视频 | 国产一区私人高清影院 | 波多野结衣视频免费 | 亚洲视频在线视频 | 久久99国产精一区二区三区! | 欧美成人在线免费观看 | 在线看片欧美 | 天堂一区二区三区精品 | 亚洲最大免费视频网 | 一区二区在线播放福利视频 | 好吊妞998视频免费观看在线 | 黄色免费在线网址 | 一个人看的www片免费视频中文 | 999热成人精品国产免 | 久久精视频 | 中文字幕日韩一区二区不卡 | 欧美精品v欧洲精品 | 亚洲一区二区三区久久久久 | 日韩乱淫 | 91青草久久久久久清纯 | 亚洲精品日本高清中文字幕 | 99热久久国产这里是精品 | 国产免费爽爽视频免费可以看 | 免费特级毛片 | 黄色美女免费看 | 性欧美一级 | 国产女王丨vk | xp123欧美亚洲国产日韩 | 一级视频免费观看 | 国产美女视频网站 | 美女视频网站免费播放视 | 国产成人深夜福利在线观看 | 久久韩国 | 一区在线观看 | 玖玖国产在线 | 国产免费人成在线看视频 | 一级做a爰全过程免费视频毛片 | 久久免费视频8 | 亚洲国产精品综合久久网络 | 亚洲国产欧美日韩 |